Mitochondria as potential targets in Alzheimer disease therapy: an update
G Cenini, W Voos - Frontiers in pharmacology, 2019 - frontiersin.org
Alzheimer disease (AD) is a progressive and deleterious neurodegenerative disorder that
affects mostly the elderly population. At the moment, no effective treatments are available in …
affects mostly the elderly population. At the moment, no effective treatments are available in …
Genetics of Alzheimer's disease
V Chouraki, S Seshadri - Advances in genetics, 2014 - Elsevier
Alzheimer's disease (AD) represents the main form of dementia, and is a major public health
problem. Despite intensive research efforts, current treatments have only marginal …
problem. Despite intensive research efforts, current treatments have only marginal …
TOMM40 Genetic Variants Cause Neuroinflammation in Alzheimer's Disease
YC Chen, SC Chang, YS Lee, WM Ho… - International Journal of …, 2023 - mdpi.com
Translocase of outer mitochondrial membrane 40 (TOMM40) is located in the outer
membrane of mitochondria. TOMM40 is essential for protein import into mitochondria …
membrane of mitochondria. TOMM40 is essential for protein import into mitochondria …
Statistical testing in transcriptomic‐neuroimaging studies: A how‐to and evaluation of methods assessing spatial and gene specificity
Multiscale integration of gene transcriptomic and neuroimaging data is becoming a widely
used approach for exploring the molecular underpinnings of large‐scale brain organization …
used approach for exploring the molecular underpinnings of large‐scale brain organization …
Sirtuins in Alzheimer's disease: SIRT2-related genophenotypes and implications for pharmacoepigenetics
R Cacabelos, JC Carril, N Cacabelos… - International journal of …, 2019 - mdpi.com
Sirtuins (SIRT1-7) are NAD+-dependent protein deacetylases/ADP ribosyltransferases with
important roles in chromatin silencing, cell cycle regulation, cellular differentiation, cellular …
important roles in chromatin silencing, cell cycle regulation, cellular differentiation, cellular …
Genome‐wide association and multi‐omics studies identify MGMT as a novel risk gene for Alzheimer's disease among women
Introduction Variants in the tau gene (MAPT) region are associated with breast cancer in
women and Alzheimer's disease (AD) among persons lacking apolipoprotein E ε4 (ε4–) …
women and Alzheimer's disease (AD) among persons lacking apolipoprotein E ε4 (ε4–) …
Signaling Mechanisms of Selective PPARγ Modulators in Alzheimer's Disease
Alzheimer's disease (AD) is a chronic neurodegenerative disease characterized by
abnormal protein accumulation, synaptic dysfunction, and cognitive impairment. The …
abnormal protein accumulation, synaptic dysfunction, and cognitive impairment. The …
Definitive roles of TOMM40-APOE-APOC1 variants in the Alzheimer's risk
AM Kulminski, I Philipp, L Shu, I Culminskaya - Neurobiology of aging, 2022 - Elsevier
Despite advances, the roles of genetic variants from the APOE-harboring 19q13. 32 region
in Alzheimer's disease (AD) remain controversial. We leverage a comprehensive approach …
in Alzheimer's disease (AD) remain controversial. We leverage a comprehensive approach …
APOE Locus-Associated Mitochondrial Function and Its Implication in Alzheimer's Disease and Aging
EG Lee, L Leong, S Chen, J Tulloch, CE Yu - International Journal of …, 2023 - mdpi.com
The Apolipoprotein E (APOE) locus has garnered significant clinical interest because of its
association with Alzheimer's disease (AD) and longevity. This genetic association appears …
association with Alzheimer's disease (AD) and longevity. This genetic association appears …
[HTML][HTML] The broad impact of TOM40 on neurodegenerative diseases in aging
WK Gottschalk, MW Lutz, YT He… - Journal of Parkinson's …, 2014 - ncbi.nlm.nih.gov
Mitochondrial dysfunction is an important factor in the pathogenesis of age-related diseases,
including neurodegenerative diseases like Alzheimer's and Parkinson's spectrum disorders …
including neurodegenerative diseases like Alzheimer's and Parkinson's spectrum disorders …